Literature DB >> 3046636

The absence of long-term therapeutic effect of calcium channel blockade in the primary aldosteronism of adrenal adenomas.

M Bursztyn1, E Grossman, T Rosenthal.   

Abstract

The absence of long-term effect of calcium channel blockers in primary aldosteronism due to adrenal adenoma is described in two patients. Calcium entry channel blockers, which were claimed to be a new medical therapy for primary aldosteronism, neither prevented the increase of plasma aldosterone nor decreased potassium levels over time in these patients. The drugs did not even lower blood pressure in one patient. Whereas calcium channel blockers may be effective in adrenal hyperplasia, they are apparently not effective enough in the long term treatment of patients with primary aldosteronism due to adrenal adenoma.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3046636     DOI: 10.1093/ajh/1.3.88s

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  3 in total

Review 1.  [Modern pharmacological aspects of hyperaldosteronism therapy].

Authors:  M Quinkler; M Reincke
Journal:  Internist (Berl)       Date:  2006-09       Impact factor: 0.743

2.  Adrenal hyperplasia.

Authors:  J Handler
Journal:  J Clin Hypertens (Greenwich)       Date:  2002 May-Jun       Impact factor: 3.738

Review 3.  Effects of calcium channel blockers on potassium homeostasis.

Authors:  M I Freed; A Rastegar; M J Bia
Journal:  Yale J Biol Med       Date:  1991 Mar-Apr
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.